In contrast, the expression levels of RUNX1, EZH2, IKZF1, and LYL1 did not differ significantly between RCC and MDS-EB patients in the GATA2WT group (Figure 2B–E). This evidence concerns the gene EZH2 and myelodysplastic syndrome.